The latest annual report (prepared by NASTAD) on Part B and the AIDS Drug Assistance Program (ADAP) of the Ryan White HIV/AIDS Program (RWHAP) is now online. The 2020 National RWHAP Part B and ADAP Monitoring Project Annual Report has three main sections, 24 tables, and 17 charts supplementing the narrative.
The HRSA HIV/AIDS Bureau's report on ADAP can be found in its inaugural ADAP Annual Client-Level Data Report 2017, released in 2019, which presents data on clients as reported in the ADAP Data Report (ADR) data system for calendar years 2014 through 2017.
Among the highlights in the NASTAD report:
- RWHAP Part B Program Funding and Structure. Rebates, payments from pharmaceutical manufacturers, comprise the largest proportion of Part B budgets. See Tables 1 through 5, providing state-specific data on budgets.
- Effective and Comprehensive Care in Achieving an End to the HIV Epidemic (EHE). As with the overall population of RWHAP clients, clients served by Part B and ADAP in particular have much higher retention in care and viral suppression rates than the overall population of people with HIV in the U.S. See Charts 3, 4, and 5 for more details.
- Expanding and Adapting Service Delivery in a Changing Healthcare Landscape. Among the many findings: payments for client insurance premiums have grown significantly. Furthermore, ADAP client viral suppression rates are highest in those states that expanded their Medicaid programs under the Affordable Care Act (see Chart 16).